Global and Japan Huntington Disease Protein Market Insights, Forecast to 2026

Publisher Name :
Date: 28-Oct-2020
No. of pages: 126
Inquire Before Buying

Huntington Disease Protein market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Huntington Disease Protein market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Huntington Disease Protein market is segmented into

- NI-302

- NLF-HD

- P-301905

- IONIS-HTTRx

- Others

Segment by Application, the Huntington Disease Protein market is segmented into

- Alzheimer's Disease

- Kennedy's Disease

- Spinocerebellar Ataxia

- Others

Regional and Country-level Analysis

The Huntington Disease Protein market is analysed and market size information is provided by regions (countries).

The key regions covered in the Huntington Disease Protein market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Huntington Disease Protein Market Share Analysis

Huntington Disease Protein market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Huntington Disease Protein business, the date to enter into the Huntington Disease Protein market, Huntington Disease Protein product introduction, recent developments, etc.

The major vendors covered:

- AFFiRiS AG

- Ionis Pharmaceuticals, Inc.

- Neurimmune Holding AG

- nLife Therapeutics, S.L.

- reMYND NV

- Sangamo BioSciences, Inc.

- UniQure N.V.

- Voyager Therapeutics, Inc.

- Vybion, Inc.

- WAVE Life Sciences Ltd.

Global and Japan Huntington Disease Protein Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Huntington Disease Protein Product Introduction
1.2 Market Segments
1.3 Key Huntington Disease Protein Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Huntington Disease Protein Market Size Growth Rate by Type
1.4.2 NI-302
1.4.3 NLF-HD
1.4.4 P-301905
1.4.5 IONIS-HTTRx
1.4.6 Others
1.5 Market by Application
1.5.1 Global Huntington Disease Protein Market Size Growth Rate by Application
1.5.2 Alzheimer's Disease
1.5.3 Kennedy's Disease
1.5.4 Spinocerebellar Ataxia
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Huntington Disease Protein Market Size, Estimates and Forecasts
2.1.1 Global Huntington Disease Protein Revenue 2015-2026
2.1.2 Global Huntington Disease Protein Sales 2015-2026
2.2 Global Huntington Disease Protein, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Huntington Disease Protein Historical Market Size by Region (2015-2020)
2.3.1 Global Huntington Disease Protein Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Huntington Disease Protein Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Huntington Disease Protein Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Huntington Disease Protein Sales Forecast by Region (2021-2026)
2.4.2 Global Huntington Disease Protein Revenue Forecast by Region (2021-2026)
3 Global Huntington Disease Protein Competitor Landscape by Players
3.1 Global Top Huntington Disease Protein Sales by Manufacturers
3.1.1 Global Huntington Disease Protein Sales by Manufacturers (2015-2020)
3.1.2 Global Huntington Disease Protein Sales Market Share by Manufacturers (2015-2020)
3.2 Global Huntington Disease Protein Manufacturers by Revenue
3.2.1 Global Huntington Disease Protein Revenue by Manufacturers (2015-2020)
3.2.2 Global Huntington Disease Protein Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Huntington Disease Protein Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Huntington Disease Protein Revenue in 2019
3.2.5 Global Huntington Disease Protein Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Huntington Disease Protein Price by Manufacturers
3.4 Global Huntington Disease Protein Manufacturing Base Distribution, Product Types
3.4.1 Huntington Disease Protein Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Huntington Disease Protein Product Type
3.4.3 Date of International Manufacturers Enter into Huntington Disease Protein Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Huntington Disease Protein Market Size by Type (2015-2020)
4.1.1 Global Huntington Disease Protein Sales by Type (2015-2020)
4.1.2 Global Huntington Disease Protein Revenue by Type (2015-2020)
4.1.3 Huntington Disease Protein Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Huntington Disease Protein Market Size Forecast by Type (2021-2026)
4.2.1 Global Huntington Disease Protein Sales Forecast by Type (2021-2026)
4.2.2 Global Huntington Disease Protein Revenue Forecast by Type (2021-2026)
4.2.3 Huntington Disease Protein Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Huntington Disease Protein Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Huntington Disease Protein Market Size by Application (2015-2020)
5.1.1 Global Huntington Disease Protein Sales by Application (2015-2020)
5.1.2 Global Huntington Disease Protein Revenue by Application (2015-2020)
5.1.3 Huntington Disease Protein Price by Application (2015-2020)
5.2 Huntington Disease Protein Market Size Forecast by Application (2021-2026)
5.2.1 Global Huntington Disease Protein Sales Forecast by Application (2021-2026)
5.2.2 Global Huntington Disease Protein Revenue Forecast by Application (2021-2026)
5.2.3 Global Huntington Disease Protein Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
6.1 Japan Huntington Disease Protein Market Size YoY Growth 2015-2026
6.1.1 Japan Huntington Disease Protein Sales YoY Growth 2015-2026
6.1.2 Japan Huntington Disease Protein Revenue YoY Growth 2015-2026
6.1.3 Japan Huntington Disease Protein Market Share in Global Market 2015-2026
6.2 Japan Huntington Disease Protein Market Size by Players (International and Local Players)
6.2.1 Japan Top Huntington Disease Protein Players by Sales (2015-2020)
6.2.2 Japan Top Huntington Disease Protein Players by Revenue (2015-2020)
6.3 Japan Huntington Disease Protein Historic Market Review by Type (2015-2020)
6.3.1 Japan Huntington Disease Protein Sales Market Share by Type (2015-2020)
6.3.2 Japan Huntington Disease Protein Revenue Market Share by Type (2015-2020)
6.3.3 Japan Huntington Disease Protein Price by Type (2015-2020)
6.4 Japan Huntington Disease Protein Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan Huntington Disease Protein Sales Forecast by Type (2021-2026)
6.4.2 Japan Huntington Disease Protein Revenue Forecast by Type (2021-2026)
6.4.3 Japan Huntington Disease Protein Price Forecast by Type (2021-2026)
6.5 Japan Huntington Disease Protein Historic Market Review by Application (2015-2020)
6.5.1 Japan Huntington Disease Protein Sales Market Share by Application (2015-2020)
6.5.2 Japan Huntington Disease Protein Revenue Market Share by Application (2015-2020)
6.5.3 Japan Huntington Disease Protein Price by Application (2015-2020)
6.6 Japan Huntington Disease Protein Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan Huntington Disease Protein Sales Forecast by Application (2021-2026)
6.6.2 Japan Huntington Disease Protein Revenue Forecast by Application (2021-2026)
6.6.3 Japan Huntington Disease Protein Price Forecast by Application (2021-2026)
7 North America
7.1 North America Huntington Disease Protein Market Size YoY Growth 2015-2026
7.2 North America Huntington Disease Protein Market Facts & Figures by Country
7.2.1 North America Huntington Disease Protein Sales by Country (2015-2020)
7.2.2 North America Huntington Disease Protein Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Huntington Disease Protein Market Size YoY Growth 2015-2026
8.2 Europe Huntington Disease Protein Market Facts & Figures by Country
8.2.1 Europe Huntington Disease Protein Sales by Country
8.2.2 Europe Huntington Disease Protein Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Huntington Disease Protein Market Size YoY Growth 2015-2026
9.2 Asia Pacific Huntington Disease Protein Market Facts & Figures by Country
9.2.1 Asia Pacific Huntington Disease Protein Sales by Region (2015-2020)
9.2.2 Asia Pacific Huntington Disease Protein Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Huntington Disease Protein Market Size YoY Growth 2015-2026
10.2 Latin America Huntington Disease Protein Market Facts & Figures by Country
10.2.1 Latin America Huntington Disease Protein Sales by Country
10.2.2 Latin America Huntington Disease Protein Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Huntington Disease Protein Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Huntington Disease Protein Market Facts & Figures by Country
11.2.1 Middle East and Africa Huntington Disease Protein Sales by Country
11.2.2 Middle East and Africa Huntington Disease Protein Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 AFFiRiS AG
12.1.1 AFFiRiS AG Corporation Information
12.1.2 AFFiRiS AG Description and Business Overview
12.1.3 AFFiRiS AG Sales, Revenue and Gross Margin (2015-2020)
12.1.4 AFFiRiS AG Huntington Disease Protein Products Offered
12.1.5 AFFiRiS AG Recent Development
12.2 Ionis Pharmaceuticals, Inc.
12.2.1 Ionis Pharmaceuticals, Inc. Corporation Information
12.2.2 Ionis Pharmaceuticals, Inc. Description and Business Overview
12.2.3 Ionis Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Ionis Pharmaceuticals, Inc. Huntington Disease Protein Products Offered
12.2.5 Ionis Pharmaceuticals, Inc. Recent Development
12.3 Neurimmune Holding AG
12.3.1 Neurimmune Holding AG Corporation Information
12.3.2 Neurimmune Holding AG Description and Business Overview
12.3.3 Neurimmune Holding AG Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Neurimmune Holding AG Huntington Disease Protein Products Offered
12.3.5 Neurimmune Holding AG Recent Development
12.4 nLife Therapeutics, S.L.
12.4.1 nLife Therapeutics, S.L. Corporation Information
12.4.2 nLife Therapeutics, S.L. Description and Business Overview
12.4.3 nLife Therapeutics, S.L. Sales, Revenue and Gross Margin (2015-2020)
12.4.4 nLife Therapeutics, S.L. Huntington Disease Protein Products Offered
12.4.5 nLife Therapeutics, S.L. Recent Development
12.5 reMYND NV
12.5.1 reMYND NV Corporation Information
12.5.2 reMYND NV Description and Business Overview
12.5.3 reMYND NV Sales, Revenue and Gross Margin (2015-2020)
12.5.4 reMYND NV Huntington Disease Protein Products Offered
12.5.5 reMYND NV Recent Development
12.6 Sangamo BioSciences, Inc.
12.6.1 Sangamo BioSciences, Inc. Corporation Information
12.6.2 Sangamo BioSciences, Inc. Description and Business Overview
12.6.3 Sangamo BioSciences, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Sangamo BioSciences, Inc. Huntington Disease Protein Products Offered
12.6.5 Sangamo BioSciences, Inc. Recent Development
12.7 UniQure N.V.
12.7.1 UniQure N.V. Corporation Information
12.7.2 UniQure N.V. Description and Business Overview
12.7.3 UniQure N.V. Sales, Revenue and Gross Margin (2015-2020)
12.7.4 UniQure N.V. Huntington Disease Protein Products Offered
12.7.5 UniQure N.V. Recent Development
12.8 Voyager Therapeutics, Inc.
12.8.1 Voyager Therapeutics, Inc. Corporation Information
12.8.2 Voyager Therapeutics, Inc. Description and Business Overview
12.8.3 Voyager Therapeutics, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Voyager Therapeutics, Inc. Huntington Disease Protein Products Offered
12.8.5 Voyager Therapeutics, Inc. Recent Development
12.9 Vybion, Inc.
12.9.1 Vybion, Inc. Corporation Information
12.9.2 Vybion, Inc. Description and Business Overview
12.9.3 Vybion, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Vybion, Inc. Huntington Disease Protein Products Offered
12.9.5 Vybion, Inc. Recent Development
12.10 WAVE Life Sciences Ltd.
12.10.1 WAVE Life Sciences Ltd. Corporation Information
12.10.2 WAVE Life Sciences Ltd. Description and Business Overview
12.10.3 WAVE Life Sciences Ltd. Sales, Revenue and Gross Margin (2015-2020)
12.10.4 WAVE Life Sciences Ltd. Huntington Disease Protein Products Offered
12.10.5 WAVE Life Sciences Ltd. Recent Development
12.11 AFFiRiS AG
12.11.1 AFFiRiS AG Corporation Information
12.11.2 AFFiRiS AG Description and Business Overview
12.11.3 AFFiRiS AG Sales, Revenue and Gross Margin (2015-2020)
12.11.4 AFFiRiS AG Huntington Disease Protein Products Offered
12.11.5 AFFiRiS AG Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Huntington Disease Protein Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Huntington Disease Protein Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Huntington Disease Protein Market Segments
Table 2. Ranking of Global Top Huntington Disease Protein Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Huntington Disease Protein Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of NI-302
Table 5. Major Manufacturers of NLF-HD
Table 6. Major Manufacturers of P-301905
Table 7. Major Manufacturers of IONIS-HTTRx
Table 8. Major Manufacturers of Others
Table 9. Global Huntington Disease Protein Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Huntington Disease Protein Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Huntington Disease Protein Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Huntington Disease Protein Sales Market Share by Regions (2015-2020)
Table 13. Global Huntington Disease Protein Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Huntington Disease Protein Sales Forecast by Region (2021-2026) (K Pcs)
Table 15. Global Huntington Disease Protein Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global Huntington Disease Protein Sales Share by Manufacturers (2015-2020)
Table 17. Global Huntington Disease Protein Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Huntington Disease Protein by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Huntington Disease Protein as of 2019)
Table 19. Huntington Disease Protein Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Huntington Disease Protein Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Huntington Disease Protein Price (2015-2020) (USD/Pcs)
Table 22. Huntington Disease Protein Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Huntington Disease Protein Product Type
Table 24. Date of International Manufacturers Enter into Huntington Disease Protein Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Huntington Disease Protein Sales by Type (2015-2020) (K Pcs)
Table 27. Global Huntington Disease Protein Sales Share by Type (2015-2020)
Table 28. Global Huntington Disease Protein Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Huntington Disease Protein Revenue Share by Type (2015-2020)
Table 30. Huntington Disease Protein Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global Huntington Disease Protein Sales Share by Type (2021-2026)
Table 32. Global Huntington Disease Protein Sales by Application (2015-2020) (K Pcs)
Table 33. Global Huntington Disease Protein Sales Share by Application (2015-2020)
Table 34. Global Huntington Disease Protein Sales Share by Application (2021-2026)
Table 35. Global Huntington Disease Protein Sales Market Share Forecast by Application (2021-2026)
Table 36. Global Huntington Disease Protein Revenue by Application (2015-2020) (US$ Million)
Table 37. Global Huntington Disease Protein Revenue Market Share Forecast by Application (2021-2026)
Table 38. Japan Huntington Disease Protein Sales (K Pcs) of Key Companies (2015-2020)
Table 39. Japan Huntington Disease Protein Sales Share by Company (2015-2020)
Table 40. Japan Huntington Disease Protein Revenue (US$ Million) by Company (2015-2020)
Table 41. Japan Huntington Disease Protein Sales (K Pcs) by Type (2015-2020)
Table 42. Japan Huntington Disease Protein Sales Share by Type (2015-2020)
Table 43. Japan Huntington Disease Protein Revenue (US$ Million) Market Share by Type (2015-2020)
Table 44. Japan Huntington Disease Protein Price (K Pcs) by Type (2015-2020)
Table 45. Japan Huntington Disease Protein Sales (K Pcs) by Type (2021-2026)
Table 46. Japan Huntington Disease Protein Sales Share by Type (2021-2026)
Table 47. Japan Huntington Disease Protein Revenue (US$ Million) Market Share by Type (2021-2026)
Table 48. Japan Huntington Disease Protein Revenue Share by Type (2021-2026)
Table 49. Japan Huntington Disease Protein Price (K Pcs) by Type (2021-2026)
Table 50. Japan Huntington Disease Protein Sales (K Pcs) by Application (2015-2020)
Table 51. Japan Huntington Disease Protein Sales Share by Application (2015-2020)
Table 52. Japan Huntington Disease Protein Revenue (US$ Million) Market Share by Application (2015-2020)
Table 53. Japan Huntington Disease Protein Sales (K Pcs) by Application (2021-2026)
Table 54. Japan Huntington Disease Protein Sales Share by Application (2021-2026)
Table 55. Japan Huntington Disease Protein Revenue (US$ Million) Market Share by Application (2021-2026)
Table 56. Japan Huntington Disease Protein Revenue Share by Application (2021-2026)
Table 57. North America Huntington Disease Protein Sales by Country (2015-2020) (K Pcs)
Table 58. North America Huntington Disease Protein Sales Market Share by Country (2015-2020)
Table 59. North America Huntington Disease Protein Revenue by Country (2015-2020) (US$ Million)
Table 60. North America Huntington Disease Protein Revenue Market Share by Country (2015-2020)
Table 61. Europe Huntington Disease Protein Sales by Country (2015-2020) (K Pcs)
Table 62. Europe Huntington Disease Protein Sales Market Share by Country (2015-2020)
Table 63. Europe Huntington Disease Protein Revenue by Country (2015-2020) (US$ Million)
Table 64. Europe Huntington Disease Protein Revenue Market Share by Country (2015-2020)
Table 65. Asia Pacific Huntington Disease Protein Sales by Region (2015-2020) (K Pcs)
Table 66. Asia Pacific Huntington Disease Protein Sales Market Share by Region (2015-2020)
Table 67. Asia Pacific Huntington Disease Protein Revenue by Region (2015-2020) (US$ Million)
Table 68. Asia Pacific Huntington Disease Protein Revenue Market Share by Region (2015-2020)
Table 69. Latin America Huntington Disease Protein Sales by Country (2015-2020) (K Pcs)
Table 70. Latin America Huntington Disease Protein Sales Market Share by Country (2015-2020)
Table 71. Latin Americaa Huntington Disease Protein Revenue by Country (2015-2020) (US$ Million)
Table 72. Latin America Huntington Disease Protein Revenue Market Share by Country (2015-2020)
Table 73. Middle East and Africa Huntington Disease Protein Sales by Country (2015-2020) (K Pcs)
Table 74. Middle East and Africa Huntington Disease Protein Sales Market Share by Country (2015-2020)
Table 75. Middle East and Africa Huntington Disease Protein Revenue by Country (2015-2020) (US$ Million)
Table 76. Middle East and Africa Huntington Disease Protein Revenue Market Share by Country (2015-2020)
Table 77. AFFiRiS AG Corporation Information
Table 78. AFFiRiS AG Description and Business Overview
Table 79. AFFiRiS AG Huntington Disease Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. AFFiRiS AG Huntington Disease Protein Product
Table 81. AFFiRiS AG Recent Development
Table 82. Ionis Pharmaceuticals, Inc. Corporation Information
Table 83. Ionis Pharmaceuticals, Inc. Description and Business Overview
Table 84. Ionis Pharmaceuticals, Inc. Huntington Disease Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Ionis Pharmaceuticals, Inc. Product
Table 86. Ionis Pharmaceuticals, Inc. Recent Development
Table 87. Neurimmune Holding AG Corporation Information
Table 88. Neurimmune Holding AG Description and Business Overview
Table 89. Neurimmune Holding AG Huntington Disease Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Neurimmune Holding AG Product
Table 91. Neurimmune Holding AG Recent Development
Table 92. nLife Therapeutics, S.L. Corporation Information
Table 93. nLife Therapeutics, S.L. Description and Business Overview
Table 94. nLife Therapeutics, S.L. Huntington Disease Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. nLife Therapeutics, S.L. Product
Table 96. nLife Therapeutics, S.L. Recent Development
Table 97. reMYND NV Corporation Information
Table 98. reMYND NV Description and Business Overview
Table 99. reMYND NV Huntington Disease Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. reMYND NV Product
Table 101. reMYND NV Recent Development
Table 102. Sangamo BioSciences, Inc. Corporation Information
Table 103. Sangamo BioSciences, Inc. Description and Business Overview
Table 104. Sangamo BioSciences, Inc. Huntington Disease Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Sangamo BioSciences, Inc. Product
Table 106. Sangamo BioSciences, Inc. Recent Development
Table 107. UniQure N.V. Corporation Information
Table 108. UniQure N.V. Description and Business Overview
Table 109. UniQure N.V. Huntington Disease Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. UniQure N.V. Product
Table 111. UniQure N.V. Recent Development
Table 112. Voyager Therapeutics, Inc. Corporation Information
Table 113. Voyager Therapeutics, Inc. Description and Business Overview
Table 114. Voyager Therapeutics, Inc. Huntington Disease Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 115. Voyager Therapeutics, Inc. Product
Table 116. Voyager Therapeutics, Inc. Recent Development
Table 117. Vybion, Inc. Corporation Information
Table 118. Vybion, Inc. Description and Business Overview
Table 119. Vybion, Inc. Huntington Disease Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 120. Vybion, Inc. Product
Table 121. Vybion, Inc. Recent Development
Table 122. WAVE Life Sciences Ltd. Corporation Information
Table 123. WAVE Life Sciences Ltd. Description and Business Overview
Table 124. WAVE Life Sciences Ltd. Huntington Disease Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 125. WAVE Life Sciences Ltd. Product
Table 126. WAVE Life Sciences Ltd. Recent Development
Table 127. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 128. Key Challenges
Table 129. Market Risks
Table 130. Main Points Interviewed from Key Huntington Disease Protein Players
Table 131. Huntington Disease Protein Customers List
Table 132. Huntington Disease Protein Distributors List
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Huntington Disease Protein Product Picture
Figure 2. Global Huntington Disease Protein Sales Market Share by Type in 2020 & 2026
Figure 3. NI-302 Product Picture
Figure 4. NLF-HD Product Picture
Figure 5. P-301905 Product Picture
Figure 6. IONIS-HTTRx Product Picture
Figure 7. Others Product Picture
Figure 8. Global Huntington Disease Protein Sales Market Share by Application in 2020 & 2026
Figure 9. Alzheimer's Disease
Figure 10. Kennedy's Disease
Figure 11. Spinocerebellar Ataxia
Figure 12. Others
Figure 13. Huntington Disease Protein Report Years Considered
Figure 14. Global Huntington Disease Protein Market Size 2015-2026 (US$ Million)
Figure 15. Global Huntington Disease Protein Sales 2015-2026 (K Pcs)
Figure 16. Global Huntington Disease Protein Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Huntington Disease Protein Sales Market Share by Region (2015-2020)
Figure 18. Global Huntington Disease Protein Sales Market Share by Region in 2019
Figure 19. Global Huntington Disease Protein Revenue Market Share by Region (2015-2020)
Figure 20. Global Huntington Disease Protein Revenue Market Share by Region in 2019
Figure 21. Global Huntington Disease Protein Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Huntington Disease Protein Revenue in 2019
Figure 23. Huntington Disease Protein Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Huntington Disease Protein Sales Market Share by Type (2015-2020)
Figure 25. Global Huntington Disease Protein Sales Market Share by Type in 2019
Figure 26. Global Huntington Disease Protein Revenue Market Share by Type (2015-2020)
Figure 27. Global Huntington Disease Protein Revenue Market Share by Type in 2019
Figure 28. Global Huntington Disease Protein Market Share by Price Range (2015-2020)
Figure 29. Global Huntington Disease Protein Sales Market Share by Application (2015-2020)
Figure 30. Global Huntington Disease Protein Sales Market Share by Application in 2019
Figure 31. Global Huntington Disease Protein Revenue Market Share by Application (2015-2020)
Figure 32. Global Huntington Disease Protein Revenue Market Share by Application in 2019
Figure 33. Japan Huntington Disease Protein Sales Growth Rate 2015-2026 (K Pcs)
Figure 34. Japan Huntington Disease Protein Revenue Growth Rate 2015-2026 (US$ Million)
Figure 35. Japan Huntington Disease Protein Market Share in Global Market 2015-2026
Figure 36. Japan 5 and 10 Largest Huntington Disease Protein Players Market Share by Revenue in Huntington Disease Protein in 2019
Figure 37. Japan Huntington Disease Protein Revenue Share by Type (2015-2020)
Figure 38. Japan Huntington Disease Protein Revenue Growth Rate by Type in 2015 & 2019
Figure 39. Japan Huntington Disease Protein Revenue Share by Application (2015-2020)
Figure 40. Japan Huntington Disease Protein Revenue Growth Rate by Application in 2015 & 2019
Figure 41. North America Huntington Disease Protein Sales Growth Rate 2015-2020 (K Pcs)
Figure 42. North America Huntington Disease Protein Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. North America Huntington Disease Protein Sales Market Share by Country in 2019
Figure 44. North America Huntington Disease Protein Revenue Market Share by Country in 2019
Figure 45. U.S. Huntington Disease Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. U.S. Huntington Disease Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Canada Huntington Disease Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Canada Huntington Disease Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Europe Huntington Disease Protein Sales Growth Rate 2015-2020 (K Pcs)
Figure 50. Europe Huntington Disease Protein Revenue Growth Rate 2015-2020 (US$ Million)
Figure 51. Europe Huntington Disease Protein Sales Market Share by Country in 2019
Figure 52. Europe Huntington Disease Protein Revenue Market Share by Country in 2019
Figure 53. Germany Huntington Disease Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Germany Huntington Disease Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. France Huntington Disease Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. France Huntington Disease Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. U.K. Huntington Disease Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 58. U.K. Huntington Disease Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Italy Huntington Disease Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 60. Italy Huntington Disease Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Russia Huntington Disease Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. Russia Huntington Disease Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Asia Pacific Huntington Disease Protein Sales Growth Rate 2015-2020 (K Pcs)
Figure 64. Asia Pacific Huntington Disease Protein Revenue Growth Rate 2015-2020 (US$ Million)
Figure 65. Asia Pacific Huntington Disease Protein Sales Market Share by Region in 2019
Figure 66. Asia Pacific Huntington Disease Protein Revenue Market Share by Region in 2019
Figure 67. China Huntington Disease Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. China Huntington Disease Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Japan Huntington Disease Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Japan Huntington Disease Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. South Korea Huntington Disease Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. South Korea Huntington Disease Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. India Huntington Disease Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. India Huntington Disease Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Australia Huntington Disease Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Australia Huntington Disease Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Taiwan Huntington Disease Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Taiwan Huntington Disease Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Indonesia Huntington Disease Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Indonesia Huntington Disease Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Thailand Huntington Disease Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Thailand Huntington Disease Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Malaysia Huntington Disease Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Malaysia Huntington Disease Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Philippines Huntington Disease Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 86. Philippines Huntington Disease Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Vietnam Huntington Disease Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 88. Vietnam Huntington Disease Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Latin America Huntington Disease Protein Sales Growth Rate 2015-2020 (K Pcs)
Figure 90. Latin America Huntington Disease Protein Revenue Growth Rate 2015-2020 (US$ Million)
Figure 91. Latin America Huntington Disease Protein Sales Market Share by Country in 2019
Figure 92. Latin America Huntington Disease Protein Revenue Market Share by Country in 2019
Figure 93. Mexico Huntington Disease Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Mexico Huntington Disease Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Brazil Huntington Disease Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Brazil Huntington Disease Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Argentina Huntington Disease Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 98. Argentina Huntington Disease Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 99. Middle East and Africa Huntington Disease Protein Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa Huntington Disease Protein Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Huntington Disease Protein Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Huntington Disease Protein Revenue Market Share by Country in 2019
Figure 103. Turkey Huntington Disease Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey Huntington Disease Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Huntington Disease Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia Huntington Disease Prote
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs